Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines Read more about Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines US Application 14/355,063Filed on 2014-05-01
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components US Patent 10,160,957Filed on 2015-06-17
Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines Read more about Polyvalent Influenza Virus-Like Particles (VLPS) And Use as Vaccines Patent Cooperation TreatyPCT/US2015/029843Filed on 2015-05-08
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Read more about Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Ireland06850427.3Filed on 2006-01-10
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Read more about Attenuated Human Parainfluenza Virus, Methods And Uses Thereof United Kingdom06850427.3Filed on 2006-01-10
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Read more about Attenuated Human Parainfluenza Virus, Methods And Uses Thereof France06850427.3Filed on 2006-01-10
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Read more about Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Germany06850427.3Filed on 2006-01-10
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Read more about Attenuated Human Parainfluenza Virus, Methods And Uses Thereof Switzerland06850427.3Filed on 2006-01-10
Monoclonal Antibodies that Bind or Neutralize Dengue Virus Read more about Monoclonal Antibodies that Bind or Neutralize Dengue Virus Canada2894300Filed on 2015-06-15
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION United Kingdom1403613.1Filed on 2014-02-28